These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11288717)

  • 1. Homozygosity for a splice site mutation of the COL1A2 gene yields a non-functional pro(alpha)2(I) chain and an EDS/OI clinical phenotype.
    Nicholls AC; Valler D; Wallis S; Pope FM
    J Med Genet; 2001 Feb; 38(2):132-6. PubMed ID: 11288717
    [No Abstract]   [Full Text] [Related]  

  • 2. Met>Val substitution in a highly conserved region of the pro-alpha1(I) collagen C-propeptide domain causes alternative splicing and a mild EDS/OI phenotype.
    Symoens S; Nuytinck L; Legius E; Malfait F; Coucke PJ; De Paepe A
    J Med Genet; 2004 Jul; 41(7):e96. PubMed ID: 15235039
    [No Abstract]   [Full Text] [Related]  

  • 3. Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta/Ehlers-Danlos Syndrome overlap syndrome.
    Malfait F; Symoens S; Goemans N; Gyftodimou Y; Holmberg E; López-González V; Mortier G; Nampoothiri S; Petersen MB; De Paepe A
    Orphanet J Rare Dis; 2013 May; 8():78. PubMed ID: 23692737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical features of Ehlers-Danlos syndrome type VIIB resulting from a base substitution at the splice acceptor site of intron 5 of the COL1A2 gene.
    Carr AJ; Chiodo AA; Hilton JM; Chow CW; Hockey A; Cole WG
    J Med Genet; 1994 Apr; 31(4):306-11. PubMed ID: 8071956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII.
    Chiodo AA; Hockey A; Cole WG
    J Biol Chem; 1992 Mar; 267(9):6361-9. PubMed ID: 1556139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen.
    Byers PH; Duvic M; Atkinson M; Robinow M; Smith LT; Krane SM; Greally MT; Ludman M; Matalon R; Pauker S; Quanbeck D; Schwarze U
    Am J Med Genet; 1997 Oct; 72(1):94-105. PubMed ID: 9295084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splice site mutation causing deletion of exon 21 sequences from the pro alpha 2(I) chain of type I collagen in a patient with severe dentinogenesis imperfecta but very mild osteogenesis imperfecta.
    Nicholls AC; Oliver J; McCarron S; Winter GB; Pope FM
    Hum Mutat; 1996; 7(3):219-27. PubMed ID: 8829655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing.
    Cabral WA; Makareeva E; Colige A; Letocha AD; Ty JM; Yeowell HN; Pals G; Leikin S; Marini JC
    J Biol Chem; 2005 May; 280(19):19259-69. PubMed ID: 15728585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific mosaicism for a lethal osteogenesis imperfecta COL1A1 mutation causes mild OI/EDS overlap syndrome.
    Symoens S; Steyaert W; Demuynck L; De Paepe A; Diderich KE; Malfait F; Coucke PJ
    Am J Med Genet A; 2017 Apr; 173(4):1047-1050. PubMed ID: 28261977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
    Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
    Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteogenesis imperfecta: phenotypic heterogeneity, protein suicide, short and long collagen.
    Prockop DJ
    Am J Hum Genet; 1984 May; 36(3):499-505. PubMed ID: 6375355
    [No Abstract]   [Full Text] [Related]  

  • 12. Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV.
    Ward LM; Lalic L; Roughley PJ; Glorieux FH
    Hum Mutat; 2001 May; 17(5):434. PubMed ID: 11317364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Collagen metabolic disorders--Ehlers-Danlos syndrome and osteogenesis imperfecta].
    Nagai Y
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):801-4. PubMed ID: 3270895
    [No Abstract]   [Full Text] [Related]  

  • 14. Compound phenotype of osteogenesis imperfecta and Ehlers-Danlos syndrome caused by combined mutations in
    Lin Z; Zeng J; Wang X
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation in the pro alpha 2(I) gene (COL1A2) for type I procollagen in Ehlers-Danlos syndrome type VII: evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype.
    Vasan NS; Kuivaniemi H; Vogel BE; Minor RR; Wootton JA; Tromp G; Weksberg R; Prockop DJ
    Am J Hum Genet; 1991 Feb; 48(2):305-17. PubMed ID: 1990839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COL1-related overlap disorder: A novel connective tissue disorder incorporating the osteogenesis imperfecta/Ehlers-Danlos syndrome overlap.
    Morlino S; Micale L; Ritelli M; Rohrbach M; Zoppi N; Vandersteen A; Mackay S; Agolini E; Cocciadiferro D; Sasaki E; Madeo A; Ferraris A; Reardon W; Di Rocco M; Novelli A; Grammatico P; Malfait F; Mazza T; Hakim A; Giunta C; Colombi M; Castori M
    Clin Genet; 2020 Mar; 97(3):396-406. PubMed ID: 31794058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in collagen genes. Consequences for rare and common diseases.
    Prockop DJ
    J Clin Invest; 1985 Mar; 75(3):783-7. PubMed ID: 3884665
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
    Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
    Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical phenotypes and molecular characterisation of three patients with Ehlers-Danlos syndrome type VII.
    Nicholls AC; Sher JL; Wright MJ; Oley C; Mueller RF; Pope FM
    J Med Genet; 2000 Nov; 37(11):E33. PubMed ID: 11073542
    [No Abstract]   [Full Text] [Related]  

  • 20. COL1A1 and COL1A2 variants in Ehlers-Danlos syndrome phenotypes and COL1-related overlap disorder.
    Venable E; Knight DRT; Thoreson EK; Baudhuin LM
    Am J Med Genet C Semin Med Genet; 2023 Jun; 193(2):147-159. PubMed ID: 36896471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.